Pubblicazioni scientifiche del gruppo di ricerca sulla tematica autismo

Scientific publications of our research group on autism


Schultz S, Gould GG, Antonucci N, Brigida AL, Siniscalco D. Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?Molecules. 2021;26(7):1845. 

Alessio N, Brigida AL, Peluso G, Antonucci N, Galderisi U, Siniscalco D. Stem Cell-Derived Exosomes in Autism Spectrum Disorder. Int J Environ Res Public Health. 2020;17(3):944. 

- Siniscalco D, Antonucci N. Cellular therapy for autism spectrum disorder: a step forward to the optimal treatments. Ann Transl Med. 2019;7(Suppl 3):S110. 

Castillo MA, Urdaneta KE, Semprún-Hernández N, Brigida AL, Antonucci N, Schultz S, Siniscalco D. Speech-Stimulating Substances in Autism Spectrum Disorders. Behav Sci (Basel). 2019;9(6):60.
- Abou-Donia MB, Suliman HB, Siniscalco D, Antonucci N, ElKafrawy PDe novo Blood Biomarkers in Autism: Autoantibodies against Neuronal and Glial Proteins. Behav Sci (Basel). 2019;9(5):47. 
- Urdaneta KE, Castillo MA, Montiel N, Semprún-Hernández N, Antonucci N, Siniscalco D. Autism Spectrum Disorders: Potential Neuro-Psychopharmacotherapeutic Plant-Based Drugs. Assay Drug Dev Technol. 2018;16(8):433-444.
- Siniscalco D, Kannan S, Semprun-Hernandez N, Eshraghi AA, Brigida AL, Antonucci N. Stem cell therapy in autism: recent insights. Stem Cells Cloning 2018; 11:55-67.

Siniscalco D, Antonucci N, Rezzani R. Melatonin for Autism Spectrum Disorder: Beyond Sleep Disturbances? Autism Open Access 2018; 8(2): 142.

- Siniscalco D, Brigida AL, Antonucci N. Autism and neuro-immune-gut link. AIMS Mol Sci. 2018; 5 (2): 166-172.

-Siniscalco D, Schultz S, Brigida AL, Antonucci N. Inflammation and Neuro-Immune Dysregulations in Autism Spectrum Disorders. Pharmaceuticals (Basel). 2018; 11(2). pii: E56.

-Brigida AL, Schultz S, Cascone M, Antonucci N, Siniscalco D. Endocannabinod Signal Dysregulation in Autism Spectrum Disorders: A Correlation Link between Inflammatory State and Neuro-Immune Alterations. Int J Mol Sci. 2017; 18(7). pii: E1425.
-Iovene MR, Bombace F, Maresca R, Sapone A, Iardino P, Picardi A, Marotta R, Schiraldi C, Siniscalco D, Serra N, de Magistris L, Bravaccio C. Intestinal Dysbiosis and Yeast Isolation in Stool of Subjects with Autism Spectrum Disorders. Mycopathologia2017; 182(3-4):349-363.
-Antonucci N. Autismo: una malattia del corpo e non solo un disturbo della mentePNEI Review 1/2017, 47-57.
-Siniscalco D. Autismo ed infiammazione. PNEI Review 1/2017, 33-40.
-Inga Jácome MC, Morales Chacòn LM, Vera Cuesta H, Maragoto Rizo C, Whilby Santiesteban M, Ramos Hernandez L, Noris García E, González Fraguela ME, Fernandez Verdecia CI, Vegas Hurtado Y, Siniscalco D, Gonçalves CA, Robinson-Agramonte ML. Peripheral Inflammatory Markers Contributing to Comorbidities in Autism. Behav Sci. 2016; 6(4). pii: E29.

-Pavan E, Siniscalco D. Autism or New Autisms? A Psychologist Point of View. Autism Open Access 2016; 6:e140.

-Vecchione R, Picariello N, Khodor Haidar Hassan, Del Corso F, Corcos L, Nappi A, Mauro U, Antonucci N. Applications of low pressure hyperbaric chamber oxygen therapy in autism spectrum disorders: a prospective randomized study of 30 children. International Journal of Current Research. 2016; 8(05): 30587-30598.

“Applications of low pressure hyperbaric chamber oxygen therapy in autism Spectrumdisorders: A prospective Andomized study of
International Journal of Current Research, 8, (05),

-Siniscalco D, Brigida AL, Brighenti M. New born alliance for autism care and research: an italian experience. Autism OpenAccess. 2016, 6(3): e139.

-Siniscalco D, Mijatovic T, Bosmans E, Cirillo A, Kruzliak P, Lombardi VC, DE Meirleir K, Antonucci N. Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder. In Vivo. 2016 03-04;30(2):83-89.

-Antonucci N, Cirillo A, Siniscalco D. Beneficial Effects of Palmitoylethanolamide on Expressive Language, Cognition, and Behaviors in Autism: A Report of Two Cases. Case Rep Psychiatry. 2015;2015:325061.

-Siniscalco D, Gallone G. A Step Forward for Autism: The New Declaration by European Union.  Autism Open Access 2015, 6(1): e137.

-Siniscalco D. Commentary: The impact of neuroimmune alterations in autism spectrum disorders. Front Psychiatry. 2015; 6:145. 

-Siniscalco D, Gallone G. A new opportunity for autism: the first specific Italian law. Autism Open Access 2015; 5:e135. 

-Siniscalco D, Luongo C. Research Hypothesis in Autism: The Role of Therapeutical Ozone. Autism Open Access 2015; 5:e129. 

-Siniscalco D. Adhesion G-protein Coupled Receptors in Autism. Autism-Open Access 2014; 4:e126. 

-Bradstreet JJ, Sych N, Antonucci N, Klunnik M, Ivankova O, Matyashchuk I, Demchuk M, Siniscalco D. Efficacy of fetal stem cell transplantation in autism spectrum disorders: an open-labeled pilot study. Cell Transplant. 2014; 23 Suppl 1:105-112. 

-Siniscalco D, Antonucci N. Autismo: le nuove frontiere. PNEI 2014; 6: 20-23. 

-Siniscalco D. Gut Bacteria-Brain Axis in Autism. A Strategy for Early Intervention? Autism. 2014; 4: e124. 

-Amet L, Hornig M, Antonucci N, Herbert M, Snape M, Stejskal V, Siniscalco D. Changing the course of autism: The science and intervention. OA Autism 2014; 2(1):1. 

-Siniscalco D. The searching for autism biomarkers: a commentary on: a new methodology of viewing extra-axial fluid and cortical abnormalities in children with autism via transcranial ultrasonography. Front Hum Neurosci. 2014; 8:240. 

-Siniscalco D. Endocannabinoid System as Novel Therapeutic Target for Autism Treatment. Autism. 2014; 4: e122. 

-Siniscalco D, Bradstreet JJ, Cirillo A, Antonucci N. The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages. J Neuroinflammation. 2014; 17;11(1):78. 

-Siniscalco D, Bradstreet JJ, Sych N, Antonucci N. Mesenchymal stem cells in treating autism: Novel insights. World J Stem Cells 2014; 6(2): 173-178. 

-Siniscalco D, Di Marsilio A, Antonucci N. Ethics in Autism Care. Autism. 2013;  3:e119. 

-Siniscalco D, Bradstreet JJ, Sych N, Antonucci N. Perspectives on the use of stem cells for autism treatmentStem Cells Int. 2013; 2013:262438. 

-Siniscalco D, Antonucci N. Involvement of dietary bioactive proteins and peptides in autism spectrum disorders. Curr Protein Pept Sci. 2013; 14(8):674-679. 

- Siniscalco D, Cirillo A, Bradstreet JJ, Antonucci N. Epigenetic findings in autism: new perspectives for therapy. Int J Environ Res Public Health. 2013; 10(9):4261-4273.

- de Magistris L, Picardi A, Siniscalco D, Riccio MP, Sapone A, Cariello R, Abbadessa S, Medici N, Lammers KM, Schiraldi C, Iardino P, Marotta R, Tolone C, Fasano A, Pascotto A, Bravaccio C. Antibodies against Food Antigens in Patients with Autistic Spectrum Disorders. Biomed Res Int. 2013; 2013: 729349. 

- Siniscalco D, Bradstreet JJ, Antonucci N. Therapeutic Role of Hematopoietic Stem Cells in Autism Spectrum Disorder-Related Inflammation. Front Immunol. 2013; 4: 140.

- Siniscalco D, Cubala-Kucharska M. Treatment of the Child with Autism-Newest Medical Trends. Autism. 2013; 3:110. 

- Siniscalco D, Antonucci N. Possible use of Trichuris suis ova in autism spectrum disorders therapy. Med Hypotheses. 2013; 81: 1-4. 

- Siniscalco D, Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, Fasano A, Bradstreet JJ, Maione S, Antonucci N. Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders. J Autism Dev Disord. 2013; 43(11):2686-2695

- Siniscalco D. Current Findings and Research Prospective in Autism Spectrum Disorders. Autism. 2013; S2-e001. 

- Siniscalco D., Cirillo A., Antonucci N. Nobel Prize to inducent pluripotent stem cells and cloning: a milestone for the regenerative medicine. J Regen Med 2012; 1:2. 

- Siniscalco D., Bradstreet JJ., Antonucci N. The promise of regenerative medicine and stem cell research for the treatment of autism. J Regen Med. 2012; 1:1. 

- Siniscalco D. Stem Cell Research: An Opportunity for Autism Spectrum Disorders Treatment. Autism. 2012; 2(2): 1000e106.

- Siniscalco D, Sapone A, Giordano C, Cirillo A, de Novellis V, de Magistris L, Rossi F, Fasano A, Maione S, Antonucci N. The expression of caspases is enhanced in peripheral blood mononuclear cells of autism spectrum disorder patients. J Autism Develop Dis. 2012; 42(7):1403-1410.

- Siniscalco D, Sapone A, Cirillo A, Giordano C, Maione S, Antonucci N. Autism spectrum disorders: is mesenchymal stem cell personalized therapy the future?. J Biomed Biotech. 2012, Article ID 480289.

"antonucci" - Powered by Professional Site